New drug licensed for Alzheimer’s

via The Hippocratic Post https://ift.tt/AzLiw4P

Alzheimer’s Research UK has welcomed news that the National Institute for Health and Care Excellence (NICE) has upheld appeals to review its final guidance to the NHS on the use of two new Alzheimer’s medicines. Eisai and Eli Lilly, the manufacturers of lecanemab and donanemab, argued that NICE had failed to properly account for the [...]

Read More... from New drug licensed for Alzheimer’s

The post New drug licensed for Alzheimer’s appeared first on The Hippocratic Post.